The expression of AML1-ETO9a isoform in acute myeloid leukemia M2 subtype and its clinical significance.

被引：0
|
作者：
Miao, Yu Q.
Chen, Zi X.
Cen, Jian N.
Yan, Ming
He, Jun
Qiu, Qiao Ch.
Zhang, Dong E.
机构：
[1] Soochow Univ, 1 Affiliated Hosp, Jiainsngsu Inst Hematol, Leukemia Unit, Suzhou, Peoples R China
[2] Scripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2317
引用
收藏
页码：656A / 656A
页数：1
相关论文
共 50 条
  • [31] Comparision of the Clinical and Prognostic Characteristic in Adult and Pediatric AML1/ETO-Positive Acute Myeloid Leukemia
    Yu, Guopan
    Zhou, Jiaheng
    Zhou, Jinchan
    Qiu, Jiale
    Yin, Zhao
    Yin, Changxin
    Xu, Dan
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    BLOOD, 2018, 132
  • [32] Prognostic significance of FLT3/ITD mutation in patients with AML1/ETO associated acute myeloid leukemia
    Kim, Y.-K.
    Kim, H. N.
    Lee, I. K.
    Jo, D. Y.
    Won, J. H.
    Choi, J. H.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    Park, H. S.
    Kim, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 21 - 21
  • [33] Clinical significance of the expression of different DNMT3A splice variants in Acute Myeloid Leukemia (AML)
    Beinicke, S.
    Jentzsch, M.
    Grimm, J.
    Haentschel, J.
    Bill, M.
    Goldmann, K.
    Schulz, J.
    Cross, M.
    Franke, G. -N.
    Behre, G.
    Vucinic, V.
    Poenisch, W.
    Niederwieser, D.
    Schwind, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 55 - 55
  • [34] The Expression of LEF1 Gene and its Clinical Significance in Chinese Patients with Acute Myeloid Leukemia
    Fu, Yuan
    Zhu, Huayuan
    Wu, Wei
    Xu, Jiadai
    Shen, Wenyi
    Xu, Wei
    Liu, Peng
    Li, Jianyong
    BLOOD, 2012, 120 (21)
  • [35] Clinical significance of LEA-1 expression in adult acute myeloid leukemia
    Kawada, H
    Fukuda, R
    Yoshida, M
    Takei, M
    Kobayashi, N
    Masumoto, A
    Ogawa, Y
    Sasao, T
    Kubota, N
    Watanabe, S
    Umeda, Y
    Yamauchi, K
    Yonekura, S
    Ichikawa, Y
    LEUKEMIA RESEARCH, 1996, 20 (04) : 327 - 332
  • [36] Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes
    GanLin He
    ChunYan Wang
    QingEn Li
    Huo Tan
    FuXiong Chen
    ZhenQian Huang
    BaoDan Yu
    LiXia Zheng
    RunHui Zheng
    Dan Liu
    Cancer Cell International, 14
  • [37] Clinical significance of reduced SFRP1 expression in acute myeloid leukemia
    An, Cui
    Guo, Hong
    Wen, Xiang-mei
    Tang, Chun-yan
    Yang, Jing
    Zhu, Xiao-wen
    Yin, Jia-yu
    Liu, Qing
    Ma, Ji-chun
    Deng, Zhao-qun
    Lin, Jiang
    Qian, Jun
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 2056 - 2060
  • [38] Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes
    He, GanLin
    Wang, ChunYan
    Li, QingEn
    Tan, Huo
    Chen, FuXiong
    Huang, ZhenQian
    Yu, BaoDan
    Zheng, LiXia
    Zheng, RunHui
    Liu, Dan
    CANCER CELL INTERNATIONAL, 2014, 14
  • [39] Expression of AML1-ETO immortalizes myeloid progenitors and cooperates with secondary mutations to induce granulocytic sarcoma/acute myeloid leukemia.
    Higuchi, M
    O'Brien, D
    Lenny, N
    Yang, SL
    Cai, ZL
    Downing, JR
    BLOOD, 2000, 96 (11) : 222A - 222A
  • [40] Proteomics analysis of bone marrow cells ofAcute myeloid leukemia (M2a) and its prognosis significance.
    Meng, Fan Yi
    Tian, Shuai
    Tang, Jia-Ming
    BLOOD, 2006, 108 (11) : 152B - 152B
12345